Study to Assess the Immunogenicity and Safety of GSK's Investigational Vaccine (GSK3277511A) When Given to Healthy Smokers and Ex-smokers After Administration of Shingrix Vaccine
Clinical trial NCT03894969 · COMPLETED
Trial details
- NCT number
- NCT03894969
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-23
- Primary completion
- 2020-08-31
- Enrollment
- 541
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.